Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,020.00    -110.00 (-1.54%)
Bid:
7,010.00
Ask:
7,020.00
Spread: 10.00 (0.143%)
Market Cap: £9.41b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

25 Mar 2013 07:00

RNS Number : 6946A
Diploma PLC
25 March 2013
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

25 March 2013

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update for the six months ending 31 March 2013, ahead of going into close period.

 

Trading Summary

Overall trading continues to be consistent with the Board's expectations at the time of the Interim Management Statement in January, against the macroeconomic backdrop which remains challenging, particularly in Europe. Group revenues are expected to be ca. 10% ahead of the comparable period last year, helped by a good contribution from businesses acquired during the past year. On an underlying basis, after adjusting for currency effects and acquisitions, revenues are expected to increase by ca. 3% against strong prior year comparatives.

 

The main contribution to revenue growth has been from Life Sciences where revenues have benefited from both the acquisition of DSL in June last year and from strong growth in consumable and service revenues across the businesses, which reflects the resilience of the Healthcare markets. In Seals, revenues have benefited from the acquisition of J Royal in December 2011, but underlying revenue growth is likely to be limited, given the very strong prior year comparatives, particularly in the Aftermarket businesses. In Controls, revenues have benefited from the small acquisitions completed during the past year, but the continuing weak trading conditions in Europe are likely to lead to a small decline in underlying revenue in the first half of the year.

 

Operating margins have reduced in line with expectations from record levels last year, reflecting the impact of implementing the Board's programme of planned investments to support the future growth of the business. This programme has included additional management resource to accelerate and broaden the acquisition programme. Acquisitions are an integral part of the Group's growth strategy and the pipeline of opportunities remains promising, although the current uncertain economic background has lengthened the transaction processes.

 

With a resilient business model, a good geographic spread of activities and contributions from acquisitions, the Board remains confident that further progress will be made in the second half of the year.

 

Financial Position

The Group has a robust balance sheet and has a proven track record of strong cash generation. At 31 March 2013 the Group will be in a strong net cash position, after payments of ca. £1.5m on acquisitions during the half year, seasonal working capital outflows and capital investment in the businesses.

 

The Group's results for the six months ending 31 March 2013 will be announced on Monday, 13 May 2013.

 

 

Conference Call:

 

A conference call for analysts and investors will take place at 8.00am (GMT) this morning; please contact Tulchan Communications for details.

 

 

Note: A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses then design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

 

The Group employs ca. 1,200 employees and its principal operating businesses are located in the UK, Germany, US, Canada and Australia.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 20% pa through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £680m.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGAWUPWGCP
Date   Source Headline
9th Apr 201410:09 amRNSHolding(s) in Company
25th Mar 20149:48 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSTrading Statement
26th Feb 20144:18 pmRNSHolding(s) in Company
12th Feb 20144:09 pmRNSHolding(s) in Company
5th Feb 20144:55 pmRNSHolding(s) in Company
31st Jan 201410:23 amRNSHolding(s) in Company
16th Jan 201411:00 amRNSHolding(s) in Company
15th Jan 20145:04 pmRNSResolutions of AGM
15th Jan 20147:00 amRNSInterim Management Statement
9th Dec 20134:20 pmRNSDirector/PDMR Shareholding
9th Dec 20134:10 pmRNSDirector/PDMR Shareholding
6th Dec 20137:00 amRNSAnnual Financial Report and Notice of AGM
22nd Nov 20132:00 pmRNSDirector/PDMR Shareholding
18th Nov 201311:21 amRNSAppointment of Director
18th Nov 20137:00 amRNSPreliminary Announcement of Results
4th Nov 20134:40 pmRNSSecond Price Monitoring Extn
4th Nov 20134:35 pmRNSPrice Monitoring Extension
1st Oct 201310:00 amRNSDirectorate Change
26th Sep 20137:00 amRNSTrading Statement
10th Sep 20137:00 amRNSInvestor Event
30th Jul 20137:00 amRNSInterim Management Statement
29th Jul 20134:00 pmRNSBoard Committee Changes
23rd Jul 20132:00 pmRNSHolding(s) in Company
25th Jun 201310:15 amRNSDirector/PDMR Shareholding
17th Jun 201311:30 amRNSHolding(s) in Company
30th May 20137:00 amRNSAppointment of Non-Executive Directors
15th May 20138:05 amRNSDirector/PDMR Shareholding
13th May 20137:00 amRNSHalf Yearly Report
19th Apr 20137:00 amRNSNotice of Results
2nd Apr 20134:00 pmRNSDirector Declaration
25th Mar 20137:00 amRNSTrading Statement
22nd Mar 20139:42 amRNSBoard Committee Change
14th Mar 201312:00 pmRNSEmployee Benefit Trust Dealings
21st Jan 20132:21 pmRNSDirector/PDMR Shareholding
16th Jan 20134:35 pmRNSResult of AGM
16th Jan 20137:00 amRNSInterim Management Statement
20th Dec 20124:11 pmRNSDirector/PDMR Shareholding
19th Dec 201210:56 amRNSDirector/PDMR Shareholding
10th Dec 20121:47 pmRNSAnnual Financial Report and Notice of AGM
21st Nov 20124:00 pmRNSDirector/PDMR Shareholding
19th Nov 20127:00 amRNSPreliminary Announcement
14th Nov 20127:00 amRNSAppointment of Non-Executive Director
24th Sep 20127:00 amRNSPre-Close Update
21st Sep 20121:24 pmRNSHolding(s) in Company
21st Sep 20127:00 amRNSCompany Secretary Change
10th Aug 20123:30 pmRNSDirector/PDMR Shareholding
30th Jul 20127:00 amRNSInterim Management Statement
5th Jul 20124:00 pmRNSHolding(s) in Company
14th May 201211:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.